Invention Grant
- Patent Title: Inactivated Bacillus coagulans and uses thereof for increasing physical performance
-
Application No.: US16625661Application Date: 2018-06-21
-
Publication No.: US11364268B2Publication Date: 2022-06-21
- Inventor: David Keller , Howard Allen Cash , Sean Farmer
- Applicant: Ganeden Biotech, Inc.
- Applicant Address: US OH Mayfield Heights
- Assignee: Ganeden Biotech, Inc.
- Current Assignee: Ganeden Biotech, Inc.
- Current Assignee Address: US OH Mayfield Heights
- Agency: Sughrue Mion, PLLC
- International Application: PCT/US2018/038751 WO 20180621
- International Announcement: WO2018/237143 WO 20181227
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A23L33/135
Abstract:
The present subject matter provides, inter alia, compositions and methods comprising inactivated, non-viable, or dead Bacillus coagulans bacteria such as whole dead bacterial spores and/or cells and/or particles that comprise inactivated, non-viable, or dead Bacillus coagulans bacteria. Compositions and methods comprising Bacillus coagulans peptidoglycan and/or lipoteichoic acid are also provided.
Public/Granted literature
- US20210154242A1 INACTIVATED BACILLUS COAGULANS AND USES THEREOF FOR INCREASING PHYSICAL PERFORMANCE Public/Granted day:2021-05-27
Information query
